Medidata announced the launch of the Medidata Research Alliance. This unique consortium brings together leading clinician-researchers and key opinion leaders from academia, non-profit organizations, and the life sciences industry to leverage Medidata’s expertise in Artificial Intelligence (AI) capabilities and clinical trial data to drive cutting-edge research into innovative treatments. The Medidata Research Alliance bridges data-driven insights into clinical practice, fostering scientific exploration that can be applied across multiple therapeutic areas. Press release. 

Centricity Research has acquired Morehead City, North Carolina-based Lucas Research, extending the organization’s reach and capabilities. With this acquisition, Centricity now offers contract research organizations (CROs) and sponsors access to more than 35 clinical research sites, reaching 8.5 million geographically and ethnically-diverse patients, and over 155 experienced investigators who perform trials in more than 20 therapeutic areas, including infectious disease, neurology, endocrinology, oncology, cardiology, dermatology, vaccines, and more. Press release. 

Velocity Clinical Research has expanded into Poland, acquiring its first site, ClinMedica Research. Located in Skierniewice, which is halfway between Warsaw and Lodz, the site marks the first in a series of key acquisitions targeted by the company in Poland by year’s end. In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. Press release. 

Trialbee has released its Omnichannel Connector for the Honey Platform to support the patient recruitment ecosystem with unprecedented transparency. The Omnichannel Connector is an open application programming interface (API) that centralizes and standardizes data from all recruitment partners to optimize referral quality, provide honest ROI, and enable study teams to make informed strategic and tactical decisions. It retains all the important data captured by every recruitment partner and shares results openly throughout the team, thus helping everyone understand what is and isn’t working and to continually improve how patients connect to trials. Press release. 

RxE2 announced the launch of a technology platform that redefines the clinical trial landscape. RxE2 is the first technology company to connect independent community pharmacies with the forefront of healthcare innovation, ushering in a new era of patient-centric and cost-effective clinical research. This approach leverages the extensive independent community pharmacist insights about their patients, making clinical trials more accessible and significantly reducing timelines and costs. Press release. 

WCG announced the official launch of IRB+, a service that transforms the landscape of Institutional Review Board (IRB) operations. WCG's IRB+ service has undergone rigorous pressure testing with more than 90 studies across all phases of research and a variety of indications, ensuring it maintains the integrity and quality of board reviews while accelerating operational processing, allowing for faster site activation and study start-up. Press release. 

QuantHealth announced a major product upgrade to its platform to simulate trials at scale and expedite, de-risk, and optimize drug development. The new product release, Katina, provides clinical researchers with an AI-guided workflow that simulates hundreds of thousands of potential trial protocol combinations of patient groups, treatment parameters, and different endpoints, to maximize the trial success probability, while taking into account additional operational and commercial considerations. Press release.